Kenneth L. Davis, MD, CEO of Mount Sinai Health System, Named to Modern Healthcare’s 50 Most Influential Clinical Executives Class of 2022
Mount Sinai Health System is proud to announce that Kenneth L. Davis, MD, Chief Executive Officer, is among the 2022 class of Modern Healthcare’s 50 Most Influential Clinical Executives award. The 50 Most Influential Clinical Executives award program honors individuals in healthcare who are deemed by their peers and the senior editors of Modern Healthcare to be paving the way to better health through their executive responsibility, leadership qualities, innovation, community service and achievements inside and outside of their respective organizations.
“Clinician leaders have shouldered a heavy load for healthcare organizations and the country at large throughout the past few years. We are proud to recognize those leaders who have risen to the occasion and then some,” said Fawn Lopez, Publisher of Modern Healthcare. “These 50 honorees have demonstrated leadership and innovation in a time of crisis and made a vital impact on the success of their organizations, the well-being of the healthcare workforce and the health of their patients and communities. We congratulate and thank them for their dedication to the advancement of healthcare.”
“It’s an honor to be among this incredibly accomplished Class of 2022. I want to sincerely thank Modern Healthcare for this recognition, and most importantly, each and every one of our Mount Sinai Health System employees without whom our programs, innovations, and health services would not thrive. I’m very proud of the work of our health system through many intense challenges, and I’m glad to share this recognition with them,” said Kenneth L. Davis, MD, Chief Executive Officer of Mount Sinai Health System.
Prior to becoming CEO, Dr. Davis conducted groundbreaking work in Alzheimer’s research that opened new avenues in the relief of symptoms from this devastating disease. His research led to the Food and Drug Administration’s approval of three of the first four drugs approved for Alzheimer’s disease. In addition to his role as CEO, Dr. Davis served as Dean of the Mount Sinai School of Medicine from 2003 to 2007. He served as President of the American College of Neuropsychopharmacology in 2006 and has received its Joel Elkes Research Award, Daniel H. Efron Research Award, and Paul Hoch Distinguished Service Award. The American Psychiatric Association has honored Dr. Davis’s work, and in 2002 he was elected to the Institute of Medicine of the National Academy of Science. In 2009, Yale University presented Dr. Davis with the George H. W. Bush ’48 Lifetime of Leadership Award, an honor given to Yale alumni athletes who make significant breakthroughs in their professions.
This year’s honorees are profiled in the June 20 issue of MH magazine and online here (digital subscription required).
Contact for information or questions on the 50 Most Influential Clinical Executives recognition program: Perry C. Juliano Perry.Juliano@modernhealthcare.com
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach
May 15, 2023 View All Press Releases
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Oct 31, 2022 View All Press Releases
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Oct 18, 2022 View All Press Releases